- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 30.33M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $68.46M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $68.77M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $121.09M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $39.2M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $143.35M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $96.01M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $207.55M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $229.49M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $369.44M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $354.48M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.14B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.16B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 28.91M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $204K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $70.76M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $582.81M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $606.03M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.96 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.96 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $19.62M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$16.98M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$17.91M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $29.45M |
| Revenue | Q1 2025 · Mar 31, 2024 | $92.96M |